Waters Corporation's stock surged 6.86% during pre-market trading on Tuesday, following the release of its first-quarter fiscal 2026 financial results.
The company reported adjusted earnings per share of $2.70, significantly beating analyst estimates of approximately $2.34, and revenue of $1.27 billion, which also exceeded consensus expectations of around $1.20 billion. The strong performance was driven by the recent acquisition of Biosciences and Diagnostic Solutions, which contributed $520 million in revenue, and solid organic growth within its Analytical Sciences Division.
Furthermore, Waters raised its full-year 2026 outlook, increasing its organic constant currency revenue growth guidance to 6.5%-8.0% and lifting its adjusted EPS forecast to a range of $14.40 to $14.60. The positive results and improved guidance have fueled investor optimism, leading to the significant pre-market gain.
Comments